Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

Concepts of Epidemiology, 2008, with permission from Oxford University Press. __OOHHCCMM__1100ee..iinnddbb 775511 0022//0055//22001177 1199::0088 .cte ,slavretni ecnerefeR 752 Biochemistry reference intervals See p662 for the philosophy of the normal range; see OHCS p220 for children. Drugs (and other substances) may interfere with any chemical method; as these ef- fects may be method dependent, it is diffi cult for the clinician to be aware of all the possibilities. If in doubt, discuss with the lab. Table 17.1 Reference interval Your Substance Specimen (labs vary, so a guide only) hospital Adrenocorticotrophic hormone P <80ng/L Alanine aminotransferase (ALT) P 5–35U/L Albumin1 P 35–50g/L Aldosterone2 P 100–500pmol/L Alkaline phosphatase1 P 30–130U/L (adults) -amylase P 0–180IU/dL -fetoprotein S <10kU/L Angiotensin II2 P 5–35pmol/L Antidiuretic hormone (ADH) P 0.9–4.6pmol/L Aspartate transaminase P 5–35U/L Bicarbonate1 P 24–30mmol/L Bilirubin P 3–17μmol/L BNP (see p137) P <50ng/L C-reactive protein P <10mg/L Calcitonin P <0 . 1mcg/L Calcium (ionized) P 1 . 0–1 . 25mmol/L Calcium1 (total) P 2.12–2.60mmol/L See p676 to correct for albumin Chloride P 95–105mmol/L Cholesterol3 (see p690) P <5.0mmol/L VLDL (see p690) P 0.128–0.645mmol/L LDL P <2.0mmol/L HDL P 0.9–1.93mmol/L Cortisol P AM 450–700nmol/L Midnight 80–280nmol/L Creatine kinase (CK) P  25–195U/L  25–170U/L Creatinine1 (proportional
